NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index is composed of all of the components of the S&P 500® Health Care Index (the "parent index").
The parent index is designed to measure the performance of common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard ("GICS®").
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
PODD | Insulet Corporation | Healthcare | Medical Devices | 2.17% |
DXCM | DexCom Inc | Healthcare | Medical Devices | 2.08% |
IDXX | IDEXX Laboratories Inc | Healthcare | Diagnostics & Research | 2.07% |
CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 2.03% |
HCA | HCA Holdings Inc | Healthcare | Medical Care Facilities | 1.96% |
COR | Cencora Inc. | Healthcare | Medical Distribution | 1.94% |
RMD | ResMed Inc | Healthcare | Medical Instruments & Supplies | 1.93% |
ALGN | Align Technology Inc | Healthcare | Medical Instruments & Supplies | 1.92% |
UHS | Universal Health Services Inc | Healthcare | Medical Care Facilities | 1.90% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 1.88% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 1.87% |
EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.87% |
CNC | Centene Corp | Healthcare | Healthcare Plans | 1.87% |
CI | Cigna Corp | Healthcare | Healthcare Plans | 1.86% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.85% |
CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.85% |
DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 1.85% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 1.82% |
COO | The Cooper Companies, Inc | Healthcare | Medical Instruments & Supplies | 1.81% |
LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.80% |